Sakar Healthcare Limited announced that it has entered into a subscription agreement of 23,09,910 equity shares at an issue price of INR 259.75 per equity share for the gross proceeds of INR 599.999123 million on August 3, 2023. The transaction will include participation from new investor, Tata Mutual Fund - Tata India Pharma & Healthcare Fund, a fund managed by, Tata Investment Corporation Limited for 10.8% stake in the company. The shares will be issued on preferential basis.

The transaction has been approved by the shareholders of the company.